Literature DB >> 22865899

Pubertal timing, androgens, and obesity phenotypes in women at midlife.

Maria E Bleil1, Bradley M Appelhans, Nancy E Adler, Steven E Gregorich, Barbara Sternfeld, Marcelle I Cedars.   

Abstract

CONTEXT: Individuals with metabolically healthy or benign obesity vs. unhealthy or at risk obesity have been distinguished; however, the predisposing factors for developing these phenotypes are poorly understood.
OBJECTIVE: Our objective was to examine pubertal timing marked by menarcheal age in relation to at-risk obese, benign obese, and healthy normal-weight phenotypes at midlife and to characterize the potential role of androgens, marked by the free androgen index (FAI), in accounting for any associations between menarcheal age and obesity phenotype.
DESIGN: The study was cross-sectional. SETTING AND PARTICIPANTS: Participants included a multiethnic community sample of 989 premenopausal women ages 25-45 yr (mean=35.2 yr; sd=5.5 yr). MAIN OUTCOME MEASURE: Membership in at-risk obese, benign obese, and healthy normal-weight groups was defined by body mass index and number of metabolic syndrome components.
RESULTS: With each 1-yr increase in menarcheal age, the probability of having the at-risk obese compared with the healthy normal-weight phenotype decreased by 22%. This association attenuated when FAI was covaried, suggesting androgen levels may account for this association. In addition, higher FAI was independently related to having the at-risk obese compared with the healthy normal-weight phenotype as well as having the at-risk compared with the benign obese phenotype (all P<0.05).
CONCLUSIONS: Younger menarcheal age is associated with having the metabolically unhealthy obesity phenotype compared with the healthy normal-weight phenotype at midlife. This relation may be driven by levels of bioavailable androgens, which were especially elevated among women with the at-risk obesity phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865899      PMCID: PMC3462930          DOI: 10.1210/jc.2012-1972

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88.

Authors:  B K Jacobsen; K Oda; S F Knutsen; G E Fraser
Journal:  Int J Epidemiol       Date:  2009-02       Impact factor: 7.196

2.  Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN).

Authors:  Kim Sutton-Tyrrell; Rachel P Wildman; Karen A Matthews; Claudia Chae; Bill L Lasley; Sarah Brockwell; Richard C Pasternak; Donald Lloyd-Jones; Mary Fran Sowers; Javier I Torréns
Journal:  Circulation       Date:  2005-03-15       Impact factor: 29.690

3.  Association of low age at menarche with increased all-cause mortality: a 37-year follow-up of 61,319 Norwegian women.

Authors:  Bjarne K Jacobsen; Ivar Heuch; Gunnar Kvåle
Journal:  Am J Epidemiol       Date:  2007-09-17       Impact factor: 4.897

Review 4.  Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.

Authors:  Jun Ren; Robert O Kelley
Journal:  Obesity (Silver Spring)       Date:  2009-02-12       Impact factor: 5.002

5.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

6.  Identification and characterization of metabolically benign obesity in humans.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Jürgen Machann; Fritz Schick; Claus Thamer; Kilian Rittig; Bernd Balletshofer; Fausto Machicao; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Arch Intern Med       Date:  2008-08-11

7.  The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Sandhya Chhabra; Christine A Eagleson; Richard Yoo; R Jeffrey Chang; Carol M Foster; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 5.958

Review 8.  Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up.

Authors:  Marion J Franz; Jeffrey J VanWormer; A Lauren Crain; Jackie L Boucher; Trina Histon; William Caplan; Jill D Bowman; Nicolas P Pronk
Journal:  J Am Diet Assoc       Date:  2007-10

9.  A simultaneous evaluation of 10 commonly used physical activity questionnaires.

Authors:  D R Jacobs; B E Ainsworth; T J Hartman; A S Leon
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

Review 10.  Public health implications of altered puberty timing.

Authors:  Mari S Golub; Gwen W Collman; Paul M D Foster; Carole A Kimmel; Ewa Rajpert-De Meyts; Edward O Reiter; Richard M Sharpe; Niels E Skakkebaek; Jorma Toppari
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

View more
  4 in total

1.  Age at menarche, androgen concentrations, and midlife obesity: findings from the Midlife Women's Health Study.

Authors:  Lisa Gallicchio; Jodi A Flaws; Rebecca L Smith
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

Review 2.  Puberty and perimenopause: reproductive transitions and their implications for women's health.

Authors:  Lindsay Till Hoyt; April M Falconi
Journal:  Soc Sci Med       Date:  2015-03-14       Impact factor: 4.634

Review 3.  Weighing the impact of obesity on female reproductive function and fertility.

Authors:  Emily S Jungheim; Jennifer L Travieso; Margaret M Hopeman
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

4.  Body size trajectories and cardio-metabolic resilience to obesity.

Authors:  W Johnson
Journal:  Nutr Bull       Date:  2018-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.